肌钙蛋白与B型利钠肽对系统性硬化症心脏受累的诊断价值:系统综述
本研究系统检索MEDLINE、EMBASE和PubMed数据库,纳入12项成人系统性硬化症(SSc)研究,评估心肌肌钙蛋白(cTn)和B型利钠肽(BNP/NT-proBNP)对SSc心脏受累(SHI)的诊断价值。四项心脏磁共振研究中三项未发现心脏生物标志物与影像学改变相关,而超声心动图异常、心律失常和充血性心力衰竭更可能与心脏生物标志物升高相关。由于SHI定义和纳入标准高度异质,现有数据不足以得出明确结论。
要点
- cTn和BNP/NT-proBNP对SHI的诊断价值证据不足,无法定论。
- 心脏生物标志物升高更与超声心动图异常、心律失常和心衰相关。
- 心脏磁共振影像改变与心脏生物标志物多无关联。
核心结论
- 现有数据不足以就cTn和BNP/NT-proBNP在SHI诊断中的作用得出明确结论。
- 现有文献提示心脏生物标志物可能与其他诊断手段联合用于识别SHI。
研究设计与样本
- 系统文献综述,检索MEDLINE(Ovid)、EMBASE和PubMed数据库。
- 纳入标准为成人、至少10例SSc患者、以SHI为主要焦点且包含cTn和BNP或NT-proBNP数据的研究。
- 仅纳入队列研究和病例对照研究,采用纽卡斯尔-渥太华质量评估量表评价证据质量。
主要发现
- 数据库检索共识别2742项研究,最终12篇文章符合纳入标准。
- 评估SHI的四项心脏磁共振成像研究中,三项未发现心脏生物标志物与影像学改变之间的关联。
- 超声心动图异常、心律失常和充血性心力衰竭更可能与心脏生物标志物升高相关。
- 研究间SHI定义和纳入标准高度异质,限制了结果比较。
临床怎么用
- 心脏生物标志物不宜单独用于SHI诊断,可考虑与其他诊断手段联合使用。
- 对SSc患者评估心脏受累时,需结合超声心动图、心律监测和临床心衰评估综合判断。
局限性
- 研究间SHI定义和纳入标准高度异质,限制结果比较。
- 现有数据不足以得出明确结论,该领域亟需临床研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic sclerosis (SSc) heart involvement (SHI) is a leading cause of SSc-associated mortality and once clinically overt, carries a very poor prognosis. There remain no established diagnostic criteria for SHI. This study aimed to systematically review the literature regarding the role of cardiac troponin (cTn) and B-type natriuretic peptide (BNP) or N-terminal B-type natriuretic peptide (NT-proBNP) in the diagnosis of SHI. METHODS: A comprehensive search of the MEDLINE (Ovid), EMBASE and Pubmed databases was performed to identify adult human studies of at least 10 SSc patients with a primary focus of SHI that included data on cTn and BNP or NT-proBNP results. Only cohort studies and case-controlled studies were identified and the quality of the evidence presented in each study was assessed according to the Newcastle-Ottawa Quality Assessment Scale. RESULTS: Of the 2742 studies identified by the database search, 12 articles fulfilled the study inclusion criteria. Three out of four studies evaluating SHI using cardiac magnetic resonance imaging found no association between cardiac biomarkers and imaging changes. By comparison echocardiographic abnormalities, cardiac arrhythmias and congestive cardiac failure were more likely to be associated with elevated cardiac biomarkers. Comparison of results between studies was limited by the highly heterogenous definitions of SHI and inclusion criteria employed across studies. CONCLUSION: There are insufficient data to draw definitive conclusions about the role of cTn and BNP / NT-proBNP in the diagnosis of SHI. Currently available literature suggests that cardiac biomarkers may have some role, in conjunction with other diagnostic modalities, in identifying SHI; however, this remains a much-needed area of clinical research.
引用
- Ross L, Moxey J, Nikpour M, et al. Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review. Semin Arthritis Rheum. 2020. PMID: 33434765. doi:10.1016/j.semarthrit.2020.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。